Complexin II plays a positive role in Ca2+-triggered exocytosis by facilitating vesicle priming by Cai, Haijiang et al.
Complexin II plays a positive role in Ca2-triggered
exocytosis by facilitating vesicle priming
Haijiang Caia,1, Kerstin Reimb, Frederique Varoqueauxb, Sompol Tapechuma,2, Kerstin Hillc,3, Jakob B. Sørensenc,
Nils Broseb, and Robert H. Chowa,4
aDepartment of Physiology and Biophysics, Keck School of Medicine, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA 90089;
bDepartment of Molecular Neurobiology and Center for the Molecular Physiology of the Brain, Max Planck Institute of Experimental Medicine, D-37075
Go¨ttingen, Germany; and cDepartment of Membrane Biophysics, Max Planck Institute for Biophysical Chemistry, D-37077 Go¨ttingen, Germany
Communicated by Clay M. Armstrong, University of Pennsylvania, Philadelphia, PA, October 10, 2008 (received for review August 3, 2008)
SNARE-mediated exocytosis is a multistage process central to
synaptic transmission and hormone release. Complexins (CPXs) are
small proteins that bind very rapidly and with a high affinity to the
SNARE core complex, where they have been proposed recently to
inhibit exocytosis by clamping the complex and inhibiting mem-
brane fusion. However, several other studies also suggest that
CPXs are positive regulators of neurotransmitter release. Thus,
whether CPXs are positive or negative regulators of exocytosis is
not known, much less the stage in the vesicle life cycle at which
they function. Here, we systematically dissect the vesicle stages
leading up to exocytosis using a knockout-rescue strategy in a
mammalian model system. We show that adrenal chromaffin cells
from CPX II knockout mice exhibit markedly diminished releasable
vesicle pools (comprising the readily and slowly releasable pools),
while showing no change in the kinetics of fusion pore dilation or
morphological vesicle docking. Overexpression of WT CPX II—but
not of SNARE-binding-deficient mutants—restores the size of the
the releasable pools in knockout cells, and in WT cells it markedly
enlarges them. Our results show that CPXs regulate the size of the
primed vesicle pools and have a positive role in Ca2-triggered
exocytosis.
chromaffin cell  large dense core vesicle  SNARE complex
Properly regulated exocytosis is important for the release ofneurotransmitters and hormones from membrane-delimited
vesicles. Secretory vesicles must dock at the plasma membrane and
then undergo priming or maturation to become ‘‘readily releas-
able’’—that is, competent to fuse rapidly with the plasma mem-
brane in response to a Ca2 trigger. It is generally accepted that
exocytosis is mediated by SNARE proteins, whose function is fine
tuned through interaction with other proteins (1). Three SNARE
proteins comprise theminimalmachinery underlying vesicle fusion:
one vesicle membrane protein synaptobrevin (also called VAMP:
vesicle-associated membrane protein) and the two plasma mem-
brane proteins, syntaxin and SNAP-25 (2–4). These 3 proteins form
a stable 4-helical bundle called the SNARE core complex that
drives intracellularmembrane fusion. Although in vitro studies have
shown that these 3 SNARE proteins alone suffice to fuse the
membranes of artificial liposomes, the rate of such fusions is orders
of magnitude slower than fusion in regulated exocytosis, which
takes place on a millisecond time scale (5, 6), indicating that
additional factors are involved in fast regulated secretion.
Complexin (CPX) is a small neuronal protein that binds very
rapidly (5  107M1s1) and with a 1:1 stoichiometry and high
affinity to the SNARE core complex (7–12), which is indicative of
a regulatory role in fast exocytosis. Four CPX isoforms have been
identified in vertebrates, CPX I - IV (13). They all are enriched
particularly in the nervous system, where they exhibit a differential
distribution, but some CPXs are also found in other tissues (7, 13).
The function of CPXs in regulated exocytosis is still a matter of
controversy. Several early studies indicated that CPXs play a
negative role in regulated exocytosis. Injection of recombinantCPX
II caused depression of release, presynaptic injection of anti-CPX
II antibody into Aplysia buccal ganglia neurons stimulated neuro-
transmitter release (14), and overexpression of CPX I or CPX II in
PC12 cells was reported to suppress acetylcholine (ACh) release
(15). More recent studies showed that cell–cell fusion of cells that
express SNAREs facing extracellularly is inhibited by CPX (16–18)
and that overexpression of a synaptobrevin CPX fusion protein,
which is thought to cause high presynaptic levels of CPX, inhibits
synaptic transmission (19). The inhibitory role of CPX was further
supported by the result that spontaneous release was increased in
the Drosophila neuromuscular junction where CPX was knocked
out (20). In addition, data on bovine chromaffin cells overexpress-
ing CPX II were interpreted to indicate a role of CPXs in the
regulation of fusion pore dynamics (21). Taken together, these data
led to the notion that CPXs play an inhibitory role in fusion by
clamping SNARE complexes.
Other studies, however, indicate that CPXs play a positive role in
regulated exocytosis. In pancreatic -cells, insulin secretion is
enhanced by overexpressingCPXI, anddecreased by silencingCPX
I expression with RNA interference (22). In mast cells, a knock-
down of CPX II also led to suppressed secretion (23). CPX I/II
double knockout neurons displayed dramatically reduced neuro-
transmission, associated with a change in the apparent Ca2
sensitivity of exocytosis (24). And distinct domains of CPX are
recently proposed to have different functions (25). Thus, the role of
CPX remains to be clarified (26).
For the present study, we used mouse adrenal chromaffin cells,
a well-characterized and extensively usedmodel system for studying
Ca2-triggered exocytosis, and applied several methods to dissect
out the role of CPXs in the stages of regulated exocytosis from
vesicle docking to fusion pore formation. Our data demonstrate
that CPX II has a positive role in fast vesicle exocytosis by regulating
the size of the primed vesicle pools.
Results
CPX Isoform Expression. Chromaffin cells secrete catecholamine
through the fusion of large dense core vesicles (LDCVs) with the
plasma membrane, employing the same conserved SNARE-based
fusion machinery that also mediates synaptic transmitter release
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from neurons. Because there are 4 CPX isoforms in vertebrates,
CPX I-IV (13), an important advantage of chromaffin cells is that
they express only one major CPX isoform, CPX II, and knockout
of CPX II does not up-regulate the expression of other CPX
isoforms or alter the expression level of other presynaptic proteins
(Fig. 1).
When we started colonies (24) with heterozygous CPX II/
breeding pairs, the offspring showed the expected Mendelian
assortment of genotypes (33 CPX II/, 60 CPX II/, 30 CPX
II/ in 20 randomly picked litters), indicating that gestation was
not terminated prematurely in CPX II/ or CPX II/ embryos.
CPX II/ mice appeared normal when young and were able to
reproduce. The cultured chromaffin cells of CPX II/ and CPX
II/ animals showed no morphological difference and had similar
cell size, as measured by basal membrane capacitance (4.82 0.13
pF, n 29 CPX II/ cells; 5.02 0.18 pF, n 30 CPX II/ cells).
Single Amperometric Event Characteristics in CPX II/ Cells.Because
CPXs bind to the assembled SNARE core complex (7), and
SNARE proteins are known to play a role in the behavior of the
fusion pore (27–30)—the aqueous pore that initially connects the
vesicle lumen and extracellular space during exocytosis—we tested
whether the kinetics of fusion pore dilation is altered in the CPX
II/ chromaffin cells. We used amperometry, an electrochemical
technique that directly reports the kinetics and amount of cate-
cholamine release from individual vesicles. Our results show that,
for all of the parameters examined, there is no robust difference
between CPX II/ and CPX II/mouse chromaffin cells (Fig. 2),
indicating that CPX does not affect the fusion pore formation and
dilation step of Ca2-triggered exocytosis, or its effect is very subtle.
Secretion Triggered by Trains of Depolarizations. To examine
whether other secretory steps are compromised in CPX II/
chromaffin cells, we next applied the method of membrane capac-
itance measurement, an approach for monitoring changes in the
membrane surface area of the entire plasma membrane at milli-
second time resolution. We applied a train of 8 100-ms depolar-
izations separated by 100-ms intervals (Fig. 3A), and recorded the
capacitance increase (Cm) (Fig. 3C), to obtain a measure of the
secretion capacity and dynamics. Although the total Ca2 influx
was the same for CPX II/ and CPX II/ cells (Fig. 3 B and F),
the total capacitance increasewas significantly smaller inCPX II/
cells (Fig. 3 C and G). The most significant differences in Cm
occurred during the earlier depolarizations, whereas the Cm in
response to later depolarizations, especially to the 7th and 8th
depolarizations, were indistinguishable (Fig. 3E). The selective
reduction in the response to the earlier depolarizations of the train
is consistent with a function of CPX II in rendering vesicles
release-ready, thereby increasing the size of the releasable vesicle
pools.
Secretion Triggered by Flash Photolysis of Caged Ca2. The most
direct approach to measure the size of the functional vesicle pools
in chromaffin cells is to monitor the Cm in response to a uniform
and global step elevation of the cytosolic Ca2 concentration
([Ca2]i), achieved by photolysis of caged Ca2 compounds. The
multiphasic rising Cm trace can be fitted with a triple exponential
function (28), which provides quantitative information about the
functional vesicle pools. The two fastest components correspond to
the primed (releasable) vesicle pools, comprising the readily re-
leasable pool (RRP) and the slowly releasable pool (SRP) (31).
We used the whole-cell patch clamp technique to load chromaf-
fin cells with a caged Ca2 compound (NP-EGTA), andmonitored
the capacitance change upon applying a 1 ms UV (UV) flash.
Because at normal basal Ca2 concentration (500 nM), exocytosis
in CPX II/ cells is too small for accurate kinetic analysis
[supporting information (SI) Fig. S1], we increased the basal Ca2
concentration to 1–3Min our experiments, which has been shown
to increase equally both the RRP and SRP of the exocytotic burst
but not to affect the release kinetics (32).Upon flashing, the [Ca2]i
was elevated to 15–20 M (Fig. 4A). As expected (Fig. 4B), the
capacitance response wasmultiphasic for CPX II/ andCPX II/
cells. However, CPX II/ cells had a much-reduced exocytotic
burst, whereas their sustained phase was not significantly altered
(Fig. 4B). As seen in Fig. 4D, the fast and slow burst phases were
both reduced in amplitude in CPX II/ cells, but their time
constants were unchanged (Fig. 4B Inset andE), indicating that the
kinetics of vesicle pool emptying is not affected by CPX II loss. The
reduced capacitance response was confirmed to be due to reduced
secretion (and not enhanced endocytosis) by simultaneous amper-
ometry measurements of the release of oxidizable vesicle content.
The time-integral of the amperometry measurements gave traces
showing cumulative secretion, resembling those obtained by the
capacitance method (Fig. 4C), however, without the potential
confounding effects of overlapping endocytosis. These results con-
firmed that the size of the releasable vesicle pools is decreased in
CPX II/ cells.
Fig. 1. CPXs expression. (A) Western blot analyses of CPX I and CPX II
expression levels in homogenates of brain (5 g per lane) and adrenal gland
(50 g per lane) from mice of the indicated CPX I and CPX II genotypes. (B)
(Left) Western blot analyses of CPX expression levels in homogenates of brain
(5 g per lane) and adrenal gland (50 g per lane) from mice of the indicated
CPX II genotypes. (Right) Western blot analyses of the expression levels of CPX
II and selected presynaptic proteins in adrenal gland homogenates [50 g per
lane, except for SNAP-25 and Syntaxin 1 (10 g per lane) and Synaptotagmin
1 (25g per lane)] from mice of the indicated CPX II genotypes. Analyses were
conducted on 3 mice for each of the indicated CPX II genotypes, and the blots
shown are representative. CPX, Complexin; Stx 1, Syntaxin 1; Syb 2, Synapto-
brevin 2; Syt 1, Synaptotagmin 1. (C) Immuno-histochemical staining of cryo-
stat sections from WT (Left) and CPX II/ (Right) mice with antibodies against
CPX I/II. Only the medulla chromaffin cells from the WT animals show bright
CPX labeling. (Scale bar: 100 m.)
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Rescue of Secretion in CPX II/ Cells by Transducing CPX II. One
concern about experiments with knockout mice is that the pheno-
type observed may be due not only to the absence of the deleted
gene, but also to secondary and irreversible changes that do not
directly reflect the loss of the eliminated gene product, such as
compensatory changes that occur during development. We there-
fore tested whether expressing CPX II in CPX II/ cells would
rescue the diminished secretion. We generated Semliki Forest
Virus (SFV) vectors encoding either CPX II-IRES-EGFP, which
allows both CPX II and EGFP (enhanced green fluorescence
protein) to be expressed separately in the same cell, or IRES-EGFP
only (as control). EGFP serves as a marker of the infected cells that
express CPX II. The expression of CPX II and EGFP was con-
firmed by immunocytochemical labeling with an antibody to CPX
I/II (Fig. 5A). Fig. 5 and Fig. S2 illustrate that expression of CPX
II in the knockout background rescued the decreased release, and
that the time constants of the slow and rapid burst of the capaci-
tance increase were not changed (Fig. S2).
Enhanced Secretion in CPX II/ Cells by Transducing CPX II. To
investigate howoverexpression ofCPX IIwould affect secretion, we
infected WT cells with the bicistronic SFV vector encoding CPX
II-IRES-EGFP (WTCPXII), and compared the results with WT
Fig. 2. Characteristics of single
amperometric events. (A) Experi-
mental configuration of whole-cell
patch clamp combined with amper-
ometry, carbon fiber electrode
(CFE). (B) Sample amperometry re-
cording. The introduction of Ca2at
10 M via the pipette triggers exo-
cytotic events at such a frequency
that the individual amperometric
spikes, representing single-vesicle
exocytosis, are well-separated. (C)
Characteristics of a single ampero-
metric event. (D–I) Cumulative dis-
tribution of single amperometric
event characteristics. (Insets) Bar
graphs show the mean  SEM of
corresponding parameters. A total
of 49 WT cells (n  49) from 6 ani-
mals (solid lines, WT) and 53 CPX
II/ cells (n  53) from 6 animals
(dashed lines, CPX II KO) were ana-
lyzed. Spikes (12–100) were re-
corded from each cell.
Fig. 3. Secretion triggered by trains
of depolarizations. (A) Voltage pro-
tocol with eight 100-ms depolariza-
tions. (B and C) Averaged ionic cur-
rents (B) and membrane capacitance
response (C) from CPX II/ (gray) and
WT (black) cells. Cm before stimulus
was subtracted. (D–G) Ca2 influxes
and Cm for each of the individual 8
depolarizations (D and E) and
summed over all 8 depolarizations (F
and G). Data were averaged from 26
experiments from 15 WT cells, 3 ani-
mals (n  26, black), and from 20
experiments from 15 CPX II/ cells, 3
animals (n 20, white). Data are ex-
pressed as mean  SEM. *, P  0.01;
**, P  0.005; ***, P  0.00005.
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cells infected by SFV encoding IRES-EGFP (WTEGFP). Again,
Ca2 influx in these two conditions showed no difference, but total
secretion was significantly increased upon CPX II overexpression
(Fig. 5G). The most significant enhancement occurred in the
second and third depolarizations and continued to a lesser extent
for several more depolarizations (Fig. 5E), indicating that the size
of the releasable vesicle pools was increased.
Ultrastructure of Wild Type and CPX II/ Cells. The sustained
response in caged Ca2 experiments (Fig. 4D) and the late re-
sponses in the trains of depolarizations (Fig. 3E) were not changed
in CPX II/ cells compared withWT cells, which suggests that the
number of docked vesicles is probably not affected by CPXs
(docked, unprimed vesicles are the precursor vesicles for resupply
of the releasable vesicle pools, after depletion has occurred; a
change in the number of precursor vesicles could lead to changes in
the net rate of primed vesicle generation). To test this idea further,
we performed electron microscopic analysis of the cultured CPX
II/ and CPX II/ chromaffin cells. We found that the number
and spatial distribution of LDCVs—in particular the number of
membrane-apposed LDCVs—were indistinguishable between
CPX II/ and CPX II/ cells (Fig. 6), indicating that vesicle
biogenesis and morphological docking are not affected by lack of
CPXs.
SNARE-Binding Is Required for the Function of CPX II. The data above
show that CPX II increases the size of the releasable vesicle pools.
To investigate if this function is related to its ability to bind the
SNARE complex, we infected CPX II/ cells with an SFV vector
encoding CPX II with a double mutation K69A/Y70A, which
effectively abolishes SNARE binding or CPX II with mutation
D29V, which does not affect SNARE binding (Fig. S3) (25). Both
mutants were in bicistronic vectors with IRES-EGFP. We then
compared the secretion in the transduced cells with CPX II/ cells
transduced with only IRES-EGFP. Our results showed that CPX II
D29V rescues the exocytotic burst, whereas CPX II K69A/Y70A
does not (Fig. S4), indicating that SNARE binding is needed for
complexin function.
Discussion
Our results showing that the fusion kinetics and the dilation of
fusion pore are not affected by CPXs were somewhat surprising: A
study (21) reported that overexpression of CPX II in bovine
chromaffin cells changed the kinetics of fusion pore dilation. That
study, however, did not report foot signals, perhaps due to the use
of digitonin to permeabilize cell membranes—an approach that has
been reported to eliminate foot signals (33). The positive role for
vesicle priming is consistent with a role upstream of synaptotagmin
1, and the unaffected fusion kinetics and fusion pore dilation
indicate that there is not an obligatory role of CPX downstream of
calcium binding to synaptotagmin 1.
Interestingly, we do not see any spontaneous secretion events
(spikes) or increase of kiss-and-run events [stand-alone foot, SAF
(34)] in CPX II/ chromaffin cells, when we perform continuous
amperometric recordings for up to 20 min (Fig. S5). We also found
no change in the vesicle distribution pattern or the vesicle number
in the CPX II/ cells (Fig. 6). These results do not support the
simplest form of the recently proposed fusion clamp hypothesis (16,
18–20), where the removal of complexin alone suffices to trigger
fusion. However, they do not rule out the possibility that complexin
may function together with another protein as a negative clamp.
Rather, our data agreewith previous work in hippocampal synapses
(24) and show that complexin has a net facilitating role during
exocytosis at the vesicle priming step, where vesicles are made
release-ready. This step seems to precede the possibly calcium-
independent association of synaptotagmin with the release machin-
ery (35).
The amino acid residues of the 4 -helices of the SNARE core
complex are aligned in register and in parallel and can be grouped
into 16 layers from the N-terminal to the C-terminal, designated
layer 7 to layer 8 (36). Studies of mutations at different layers
have indicated that the SNARE complexes are partially zipped
from N-terminal to C-terminal layer 4 or 5 during vesicle
priming (37). Interestingly, crystallographic and NMR studies have
shown that the region of CPX-SNARE interaction also extends to
layer4, and, furthermore, binding of CPXs stabilizes the SNARE
complex (10). When viewed in this context, our findings are
compatible with the idea that CPXsmay, through SNAREbinding,
Fig. 4. Exocytosis triggered by photolyzing caged Ca2. (A–C) Averaged
[Ca2]i (A), averaged secretion as monitored with membrane capacitance
measurements (B)m or with amperometry (C) from CPX II/ (gray) and WT
(black) cells. (Inset) Cm traces were scaled to the same amplitude at 1 s after
flash to compare the kinetics of Cm increases. The amperometric traces were
also integrated to show the cumulative secretion (C). (D) Analysis of the size
of burst phases and sustained rate of secretion by capacitance measurements.
Data were averaged from 13 experiments on 11 WT cells, 4 animals (black, n
13), and from 16 experiments on 11 CPX II/ cells, 5 animals (white, n  16).
**, P 0.007. (E) Analysis of the time constants of the fast and slow bursts of
secretion (WT, black, n  13; CPX II KO, white, n  14). Data are shown as
mean  SEM.
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stabilize the partially zippered SNARE conformation and the
primed vesicle state.
Materials and Methods
Chromaffin Cell Culture and Virus Infection. Mouse breeding was started in the
University of Southern California animal facility with CPX II/mice. Original CPX
mice were generated at the Max Planck Institute of Experimental Medicine,
Go¨ttingen, Germany (24). All animal care and experimental treatments were in
accordance with USC guidelines for animal care and use. For genotyping, tail
biopsies were taken from 1-week-old mice, processed according to standard
procedures, and analyzed by PCR. Mice at 8–12 days of age were used for
experiments and WT mice from the same litter were used as controls for the CPX
II/ mice in all experiments. Mouse adrenal chromaffin cells were cultured as
described in ref. 28. These cells were used at the third and 4th day after culture
preparation for all studies reported. For rescue experiments, cells were infected
with SFV as described in ref. 38 and cells were used between 15 and 30 h after SFV
infection.RecombinantDNAvectorsweremadewithstandardmolecularbiology
protocols.
Western Blot Analysis. SDS/PAGE and Western blot analysis were performed as
described in ref. 13. Immunoreactive bands were visualized with ECL (GE Health-
care).TheantibodiestoCPXI/II recognizesbothisoformsCPXIandII,butCPXIand
CPX II can be distinguished based on their different size. Other antibodies are
specific. All primary antibodies were from Synaptic Systems.
Cosedimentation Assays. Recombinant fusion proteins consisting of glutathion-
S-transferase (GST) and WT or mutant CPX II were synthesized in E. coli using the
pGEX-KG expression constructs (39). Recombinant proteins were purified on
glutathion-agarose (Sigma) and used, immobilized on the resin, for cosedimen-
tation assays. Crude synaptosomes from rat brain were solubilized at a protein
concentration of 2 mg/ml in 150 mM NaCl, 10 mM Hepes (pH 7.4), 1 mM EGTA, 2
mM MgCl2, 1% Triton X-100, 0.2 mM phenylmethylsulfonyl fluoride, 1 g/ml
aprotinin, and 0.5g/ml leupeptin (solubilization buffer). After stirring on ice for
10 min, insoluble material was removed by centrifugation (10 min at 346,000
gmax and 4 °C). The equivalent of 3 mg of total protein was then incubated with
50g of immobilized GST-fusion protein for 2 h at 4 °C. Beads were then washed
3 times with solubilization buffer, resuspended in SDS/PAGE sample buffer, and
analyzed by SDS/PAGE and immunoblotting (40, 41). All primary antibodies were
from Synaptic Systems.
Electrophysiological Experiments. Conventional whole cell patch clamp record-
ingswereperformedwiththeEPC-9amplifierandPulse softwarepackage (HEKA
Electronics) (42). A 3.5–4.5 M	 sylgard-coated pipette was used. Capacitance was
measured with the Lindau–Neher technique implemented as the ‘‘sine  dc’’
mode of the software lock-in extension of Pulse, in which a 1-kHz, 70-mV
peak-to-peak sinusoidal voltage stimulus is superimposed onto a constant hold-
ing potential of 80 mV (43). In all of the experiments the isolated chromaffin
cells were in an extracellular solution containing 140 mM NaCl, 2.8 mM KCl, 10
mM Hepes, 1 mM MgCl2, 2 mM CaCl2, 2 mM glucose, pH adjusted to 7.2–7.4 and
osmolarity adjusted to 290–310. For the experiments where exocytosis was
triggered by trains of depolarizations, the pipette solutions contained 10 mM
NaCl, 145 mM glutamic acid, 10 mM Hepes, 1 mM MgCl2; titrated with 5 M CsOH
Fig. 5. Secretion of cells transduced with
Semliki Forest Virus. (A) Immunostaining of
CPX II/ cells rescued by virus-mediated
expression of CPX II. The cell (Lower) that
expresses EGFP (green) can also be labeled
by anti-CPX II antibody (red), whereas the
cell (Upper) that does not express EGFP
shows no CPX II labeling. (B and C) Aver-
aged ionic current recordings (B) and ca-
pacitance response (C). Cm before stimulus
was subtracted. (D–G) Ca2 influxes and
Cm for each individual depolarization (D
and E) and summed over all depolarizations
(F and G). Data from WT cells expressing
EGFP are in black (WTEGFP, 38 experi-
ments from 27 cells, 7 animals, n 38), CPX
II/ cells expressing CPX II and EGFP are in
orange (KOCPX II, 27 experiments from
17 cells, 4 animals, n  27), from WT cells
overexpressing CPX II and EGFP are in red
(WTCPX II, 14 experiments from 9 cells, 3
animals, n 27). Data are shown as mean
SEM. *, P  0.05; **, P  0.005; ***, P 
0.0005.
Fig. 6. Ultrastructure of WT and CPX II/ chromaffin cells. (A) Electron
micrographs of cultured mouse adrenal chromaffin cells. (Left) WT cell. (Right)
CPX II/ cell. (B) Analysis of the cellular distribution of large dense core
vesicles (LDCVs). The distributions were calculated based on the distance from
the center of the vesicle to the plasma membrane. The numbers of LDCVs per
section in the depicted distance ranges are expressed as mean SEM. (C) Total
number of LDCVs per cell section (mean SEM). Data were averaged from 10
WT cells (black, WT), and 13 CPX II/ cells (white, CPX II KO).
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to adjust pH to 7.2–7.4, osmolarity was adjusted to 290–310, ATP/GTP 2 mM/0.3
mM was added before use.
Amperometry. Carbon fiber electrodes were prepared as described in ref. 44 and
coupled to a VA-10 amplifier (ALA Scientific Instruments). An 800-mV constant
voltage was applied to the electrode relative to Ag/AgCl bath electrode. The
amperometry recordings were low-pass filtered at 3 kHz and sampled at 10 kHz.
The pipette solution contained: 10 mM NaCl, 50 mM glutamic acid, 1 mM MgCl2,
44 mM CaCl2, 60 mM HEDTA, titrate with 5 M CsOH to pH 7.2–7.4, add ATP/GTP
2 mM/0.3 mM before use. Due to the great variability in the number of ampero-
metric events per cell, we analyzed the data in a way that gave the contribution
of each cell the same weight, regardless of the number events for a given cell (45).
For each cell and each parameter, we calculated a median value. Then we
compared the mean values of the medians of CPX II/ and CPX II/ cells.
Photolysis of Caged Ca2. Caged-Ca2 experiments were performed as described
in ref. 46 except the free calcium inside the pipette was adjusted to1M. A UV
flash was generated by a flash lamp (XF-10 xenon flash lamp system, flash bulb
XBL-XF/10; Rapp Optoelektronik), and fluorescence excitation was generated by
a monochromator (Polychrome V; TILL Photonics). These light sources were
coupled into the epifluorescence port of an inverted Axiovert 100 microscope
(Zeiss). Calcium dyes were excited at 350/380 nm and the emitted fluorescence
was detected with a cascade camera (Cascade 512B; Photometrics) operated by
MetaFluor software (Universal Imaging). In vivo Ca2 calibration was performed
as described in ref. 32. The objectives used were a 40x/1.30 Fluor objective (Zeiss).
Both capacitance and amperometry traces were exported to Igor Pro 4.0 (Wave-
Metrics), and home-written programs were used to perform the analysis. Kinetic
analysis of individual capacitance in flash experiments was performed as de-
scribed in ref. 28. The pipette solution contained 100 mM glutamic acid, 10 mM
NaCl, 40 mM Hepes; titrated with CsOH to adjust pH to 7.20 and Osm adjusted to
290–300. 5 mM NP-EGTA, 0.3 mM Furaptra and 0.2 mM Fura-2 were added just
before use, and free calcium was adjusted to1 M.
Immunostaining. For cryostat section staining, the dissected adrenal glands
werefixedwith ice-cold4%paraformaldehydeinPBSfor2handimmersed inPBS
with 30% sucrose overnight. The glands were sectioned at 12-m thickness. For
culturedcell staining, SFV-infectedchromaffincellswerewashed inPBSandfixed
with ice-cold4%paraformaldehydeinPBSfor20min.Cellsorglandsectionswere
then washed twice with PBS for 5 min and blocked by 0.2% Triton X-100, 2% goat
serum and 2% BSA in PBS for 30 min. Cells or gland sections were incubated
overnight at 4 °C with polyclonal rabbit anti-CPX I/II antibody (1:2,000; Synaptic
Systems). After washing twice with PBS, cells or gland sections were incubated at
room temperature for 1 h with Alexa Fluor 555 goat anti-rabbit IgG (Invitrogen).
Cells or gland sections were washed and mounted. The fluorescence was ana-
lyzed on an inverted Axiovert 100 microscope with a 40x/1.30 objective (Zeiss).
ElectronMicroscopy. For ultrastructural analysis, chromaffin cells were plated on
collagen-coated coverslips. After 24 h, cells were fixed with 1.5–2.5% glutaral-
dehyde in 0.1 M phosphate buffer (pH 7.4), incubated on ice for 30 min, and
washed thoroughly in phosphate buffer. Cells were postfixed for 1 h in 1% OsO4
on ice in the dark and further washed. After dehydration through a series of
ascending ethanol and propylene oxide, cells were incubated in a 1:1 propylene
oxide-Durcupan mix at room temperature and polymerized for 48 h at 60 °C in
Durcupan. 50–70 nm ultrathin sections were collected on single-slot grids cov-
ered with a Formvar membrane, and contrasted with uranyl acetate and lead
citrate solutions. Sections were observed under an LEO 912AB transmission
electronmicroscope(Zeiss). ImagesweretakenwithadigitalProScanCCDcamera
andanalyzedwiththeAnalysis3.2software(Soft-Imaging-System;Olympus).The
distance from the plasma membrane to the center of each LDCV was measured
and the number of LDCVs observed was plotted against this distance.
Statistical Analysis.Unless specified, unpaired, 2-tailed Student’s t test were used
to analyze statistical significance. P 0.05 was considered significant.
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